Red wine proves good for the heart (again)
Antioxidant compounds found in red wine are advancing the treatment of heart disease—the leading cause of death for both men and women in the U.S.
Feb 1, 2018
0
4
Antioxidant compounds found in red wine are advancing the treatment of heart disease—the leading cause of death for both men and women in the U.S.
Feb 1, 2018
0
4
ADAPT (A Direct Aspiration First-Pass Technique), a technique pioneered at the Medical University of South Carolina (MUSC), is non-inferior to stent retrievers for mechanical thrombectomy in stroke patients with large-vessel ...
Jan 25, 2018
0
3
Researchers at the St. Antonius Hospital Utrecht/Nieuwegein and the University of Twente have developed software to better predict the risk of blood leaking around a patient's aortic stent. Last week, Richte Schuurmann, a ...
Jan 16, 2018
0
3
A research team at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo has found that in stroke patients with large vessel occlusion (LVO), the removal of the clot occurs as efficiently after ...
Jan 3, 2018
0
1
New-generation stents containing anti-vasoconstriction medication perform well. They are safe and efficient for most patients, over both the short term and the long term. According to Liefke van der Heijden, a trainee cardiologist ...
Dec 5, 2017
0
0
Infants with various forms of congenital heart disease require a stable source of blood flow to their lungs in order to survive until a more definitive operation can be performed. In a recent study, pediatric researchers ...
Nov 21, 2017
0
0
(HealthDay)—Heart experts are cautiously embracing the results of a new, landmark clinical trial that questions the value of opening blocked arteries to relieve chest pain.
Nov 3, 2017
0
13
Researchers in the Division of Cardiology, School of Pharmacy and UNC McAllister Heart Institute at the University of North Carolina at Chapel Hill are part of a national study which found that a quick, precise genetic test, ...
Nov 3, 2017
0
2
Coronary artery stents are lifesaving for heart attack patients, but new research suggests that the placebo effect may be larger than previously thought.
Nov 2, 2017
0
3
Results from the prospective, multicenter, randomized investigator-initiated REDUCE trial were reported today at the 29th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular ...
Nov 2, 2017
0
0